Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has signed a Memorandum of Understanding with PRC Clinicala , a Contract Research Organization based in the San Francisco Bay Area, in anticipation of its planned Phase II multi-center ALS clinical trial in the United ... (more)
http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=23639
http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=23639
No comments:
Post a Comment